C. Diff Vaccine (high risk patients) – J. Lewis Research, Inc.
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection | NEJM
C. difficile Vaccine Candidate MVX02 | matrivax
C. diff vaccine tested in Bend and 200 other sites | Health | bendbulletin.com
Synthetic Lipoteichoic Acid Glycans Are Potential Vaccine Candidates to Protect from Clostridium difficile Infections - ScienceDirect
Pfizer's Clostridioides Difficile Vaccine Fails To Prevent C. Difficile Infection
New Research Tests C. Difficile Vaccine Efficacy - Drexel University College of Medicine
Clostridium difficile and One Health - ScienceDirect
View PDF
Cytotoxic activity of purified toxins from prevalent C. difficile... | Download Table
Safety, immunogenicity, and efficacy of a Clostridioides difficile toxoid vaccine candidate: a phase 3 multicentre, observer-blind, randomised, controlled trial - The Lancet Infectious Diseases
C. difficile pipeline vaccines could offer an alternative to antibiotics - Clinical Trials Arena
Vaccines | Free Full-Text | Mucosal Vaccination Strategies against Clostridioides difficile Infection
Development of an Effective Nontoxigenic Clostridioides difficile–Based Oral Vaccine against C. difficile Infection | Microbiology Spectrum
Vaccines | Free Full-Text | Mucosal Vaccination Strategies against Clostridioides difficile Infection
JCI Insight - Human C. difficile toxin–specific memory B cell repertoires encode poorly neutralizing antibodies
Pathogens | Free Full-Text | Non-Toxin-Based Clostridioides difficile Vaccination Approaches
New Clostridioides difficile vaccine on the horizon • healthcare-in-europe.com
A Review of Experimental and Off-Label Therapies for Clostridium difficile Infection | Infectious Diseases and Therapy
Frontiers in antibiotic alternatives for Clostridioides difficile infection
Pfizer fails phase 3 C. diff vaccine test but still spies possible path forward | Fierce Biotech
Frontiers | Immunoinformatics Approach Toward the Introduction of a Novel Multi-Epitope Vaccine Against Clostridium difficile
A DNA vaccine targeting TcdA and TcdB induces protective immunity against Clostridium difficile | BMC Infectious Diseases | Full Text
Emerging Vaccines for Clostridium difficile Infection Treatment
Percentages of participants who achieved prespecified levels of toxin... | Download Scientific Diagram
